Nuvalent, Inc. - Class A Common Stock (NUVL)

123.25
+34.76 (39.28%)
NASDAQ· Last Trade: Jun 9th, 6:31 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), SUNation Energy, Inc. (Nasdaq – SUNE), Organon & Co. (NYSE – OGN), Taylor Morrison Home Corporation (NYSE – TMHC)
BALA CYNWYD, Pa., June 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · June 9, 2026
NUVL Stock Alert: Halper Sadeh LLC is Investigating Whether Nuvalent, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Nuvalent, Inc. (NASDAQ: NUVL) to GSK plc for $124.00 per share in cash.
By Halper Sadeh LLC · Via Business Wire · June 9, 2026